EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Nickel nanoparticles: a novel platform for cancer-targeted delivery and multimodal therapy

Fengyu Wang, Sen Tong, Xuan Ma, Huan Yang, Tianbao Zhang, Kunrong Wu, Junzi Wu

Frontiers in Drug Delivery · 30.07.2025 · 5

DOI: 10.3389/fddev.2025.1627556 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Drug Delivery, online erschienen am 30.07.2025. Verfasst von Fengyu Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Key Laboratory of Microcosmic Syndrome Differentiation, Yunnan University of Chinese Medicine, Kunming, China. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Traditional cancer treatment methods often encounter limitations, such as poor targeting, low bioavailability, and high systemic toxicity. These challenges have led researchers to explore alternative therapeutic strategies. Nickel nanoparticles (NiNPs), owing to their distinctive physicochemical properties and tunable biocompatibility, have attracted considerable attention in cancer therapy and drug delivery applications. These nanomaterials demonstrate excellent magnetic properties, photothermal conversion capabilities, catalytic activity, and potential for multifunctionality and targeted drug delivery via surface modification. This review highlights recent advancements in the use of NiNPs for cancer treatment, emphasizing their advantages as drug carriers that enhance the bioavailability, targeting, and therapeutic efficacy of anticancer agents. Additionally, the synergistic applications of NiNPs in multimodal therapies, including magnetic hyperthermia, photothermal therapy, and chemodynamic therapy, are discussed, as well as their potential as theranostic platforms. Although nickel-based nanodelivery systems show significant promise for clinical translation, issues related to biosafety, degradation metabolism, and long-term toxicity remain and require further investigation to support their clinical application.

Schlagwörter

Stichwörter der Autor:innen

chemodynamic therapydrug deliverymagnetic hyperthermia therapynickel nanoparticlesphotothermal therapy

Autor:innen und Institutionen

  • The Key Laboratory of Microcosmic Syndrome Differentiation, Yunnan University of Chinese Medicine, Kunming, China.
  • Yunnan Key Laboratory of Integrated Traditional Chinese and Western Medicine for Chronic Disease in Prevention and Treatment, Yunnan University of Chinese Medicine, Kunming, China.
  • School of Chinese Medicine, Yunnan University of Chinese Medicine, Kunming, China.

Zitieren

APA

Wang, F., Tong, S., Ma, X., Yang, H., Zhang, T., Wu, K., & Wu, J. (2025). Nickel nanoparticles: a novel platform for cancer-targeted delivery and multimodal therapy. Frontiers in Drug Delivery, 5. https://doi.org/10.3389/fddev.2025.1627556

Vancouver

Wang F, Tong S, Ma X, Yang H, Zhang T, Wu K, et al. Nickel nanoparticles: a novel platform for cancer-targeted delivery and multimodal therapy. Frontiers in Drug Delivery. 2025;5. doi:10.3389/fddev.2025.1627556

BibTeX
@article{Wang2025,
  author = {Wang, Fengyu and Tong, Sen and Ma, Xuan and Yang, Huan and Zhang, Tianbao and Wu, Kunrong and Wu, Junzi},
  title = {Nickel nanoparticles: a novel platform for cancer-targeted delivery and multimodal therapy},
  journal = {Frontiers in Drug Delivery},
  year = {2025},
  volume = {5},
  doi = {10.3389/fddev.2025.1627556}
}
Kostenlos starten →